Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
The phosphatidylinositol 3-kinase (PI3K) pathway regulates various cellular processes, including cellular proliferation and intracellular trafficking, and may affect prostate carcinogenesis. Thus, we explored the association between single-nucleotide polymorphisms (SNP) in PI3K genes and prostate ca...
| Principais autores: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
2010
|
| _version_ | 1826300699728674816 |
|---|---|
| author | Koutros, S Schumacher, F Hayes, R Ma, J Huang, W Albanes, D Canzian, F Chanock, S Crawford, E Diver, W Feigelson, H Giovanucci, E Haiman, C Henderson, B Hunter, D Kaaks, R Kolonel, L Kraft, P Le Marchand, L Riboli, E Siddiq, A Stampfer, M Stram, DO Thomas, G Travis, R |
| author_facet | Koutros, S Schumacher, F Hayes, R Ma, J Huang, W Albanes, D Canzian, F Chanock, S Crawford, E Diver, W Feigelson, H Giovanucci, E Haiman, C Henderson, B Hunter, D Kaaks, R Kolonel, L Kraft, P Le Marchand, L Riboli, E Siddiq, A Stampfer, M Stram, DO Thomas, G Travis, R |
| author_sort | Koutros, S |
| collection | OXFORD |
| description | The phosphatidylinositol 3-kinase (PI3K) pathway regulates various cellular processes, including cellular proliferation and intracellular trafficking, and may affect prostate carcinogenesis. Thus, we explored the association between single-nucleotide polymorphisms (SNP) in PI3K genes and prostate cancer. Pooled data from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium were examined for associations between 89 SNPs in PI3K genes (PIK3C2B, PIK3AP1, PIK3C2A, PIK3CD, and PIK3R3) and prostate cancer risk in 8,309 cases and 9,286 controls. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using logistic regression. SNP rs7556371 in PIK3C2B was significantly associated with prostate cancer risk [OR(per allele), 1.08 (95% CI, 1.03-1.14); P(trend) = 0.0017] after adjustment for multiple testing (P(adj) = 0.024). Simultaneous adjustment of rs7556371 for nearby SNPs strengthened the association [OR(per allele), 1.21 (95% CI, 1.09-1.34); P(trend) = 0.0003]. The adjusted association was stronger for men who were diagnosed before the age of 65 years [OR(per allele), 1.47 (95% CI, 1.20-1.79); P(trend) = 0.0001] or had a family history [OR(per allele) = 1.57 (95% CI, 1.11-2.23); P(trend) = 0.0114], and was strongest in those with both characteristics [OR(per allele) = 2.31 (95% CI, 1.07-5.07), P-interaction = 0.005]. Increased risks were observed among men in the top tertile of circulating insulin-like growth factor-I (IGF-I) levels [OR(per allele) = 1.46 (95% CI, 1.04-2.06); P(trend) = 0.075]. No differences were observed with disease aggressiveness (Gleason grade >or=8 or stage T(3)/T(4) or fatal). In conclusion, we observed a significant association between PIK3C2B and prostate cancer risk, especially for familial, early-onset disease, which may be attributable to IGF-dependent PI3K signaling. |
| first_indexed | 2024-03-07T05:21:08Z |
| format | Journal article |
| id | oxford-uuid:def683d9-8a35-448a-ad32-f8c5f1c49f8c |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T05:21:08Z |
| publishDate | 2010 |
| record_format | dspace |
| spelling | oxford-uuid:def683d9-8a35-448a-ad32-f8c5f1c49f8c2022-03-27T09:36:04ZPooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:def683d9-8a35-448a-ad32-f8c5f1c49f8cEnglishSymplectic Elements at Oxford2010Koutros, SSchumacher, FHayes, RMa, JHuang, WAlbanes, DCanzian, FChanock, SCrawford, EDiver, WFeigelson, HGiovanucci, EHaiman, CHenderson, BHunter, DKaaks, RKolonel, LKraft, PLe Marchand, LRiboli, ESiddiq, AStampfer, MStram, DOThomas, GTravis, RThe phosphatidylinositol 3-kinase (PI3K) pathway regulates various cellular processes, including cellular proliferation and intracellular trafficking, and may affect prostate carcinogenesis. Thus, we explored the association between single-nucleotide polymorphisms (SNP) in PI3K genes and prostate cancer. Pooled data from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium were examined for associations between 89 SNPs in PI3K genes (PIK3C2B, PIK3AP1, PIK3C2A, PIK3CD, and PIK3R3) and prostate cancer risk in 8,309 cases and 9,286 controls. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using logistic regression. SNP rs7556371 in PIK3C2B was significantly associated with prostate cancer risk [OR(per allele), 1.08 (95% CI, 1.03-1.14); P(trend) = 0.0017] after adjustment for multiple testing (P(adj) = 0.024). Simultaneous adjustment of rs7556371 for nearby SNPs strengthened the association [OR(per allele), 1.21 (95% CI, 1.09-1.34); P(trend) = 0.0003]. The adjusted association was stronger for men who were diagnosed before the age of 65 years [OR(per allele), 1.47 (95% CI, 1.20-1.79); P(trend) = 0.0001] or had a family history [OR(per allele) = 1.57 (95% CI, 1.11-2.23); P(trend) = 0.0114], and was strongest in those with both characteristics [OR(per allele) = 2.31 (95% CI, 1.07-5.07), P-interaction = 0.005]. Increased risks were observed among men in the top tertile of circulating insulin-like growth factor-I (IGF-I) levels [OR(per allele) = 1.46 (95% CI, 1.04-2.06); P(trend) = 0.075]. No differences were observed with disease aggressiveness (Gleason grade >or=8 or stage T(3)/T(4) or fatal). In conclusion, we observed a significant association between PIK3C2B and prostate cancer risk, especially for familial, early-onset disease, which may be attributable to IGF-dependent PI3K signaling. |
| spellingShingle | Koutros, S Schumacher, F Hayes, R Ma, J Huang, W Albanes, D Canzian, F Chanock, S Crawford, E Diver, W Feigelson, H Giovanucci, E Haiman, C Henderson, B Hunter, D Kaaks, R Kolonel, L Kraft, P Le Marchand, L Riboli, E Siddiq, A Stampfer, M Stram, DO Thomas, G Travis, R Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. |
| title | Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. |
| title_full | Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. |
| title_fullStr | Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. |
| title_full_unstemmed | Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. |
| title_short | Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer. |
| title_sort | pooled analysis of phosphatidylinositol 3 kinase pathway variants and risk of prostate cancer |
| work_keys_str_mv | AT koutross pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT schumacherf pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT hayesr pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT maj pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT huangw pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT albanesd pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT canzianf pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT chanocks pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT crawforde pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT diverw pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT feigelsonh pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT giovanuccie pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT haimanc pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT hendersonb pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT hunterd pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT kaaksr pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT kolonell pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT kraftp pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT lemarchandl pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT ribolie pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT siddiqa pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT stampferm pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT stramdo pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT thomasg pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer AT travisr pooledanalysisofphosphatidylinositol3kinasepathwayvariantsandriskofprostatecancer |